Morphic Ethical Equities Fund Ltd. ( ($AU:MEC) ) has shared an update. Morphic Ethical Equities Fund Ltd. reported a -2.3% return for the month, ...

Morphic only had eyes for Eli Lilly. While some takeover tales have casts of Shakespearean breadth, Lilly’s $3.2 billion Morphic buyout is a simpler story of two companies gradually closing the gap ...

Morphic Ethical Equities Fund Ltd. ( ($AU:MEC) ) has issued an announcement. Morphic Ethical Equities Fund Ltd. has announced an update on its ...

Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for inflammatory ...

WALTHAM, Mass.–(BUSINESS WIRE)–Morphic Holding, Inc. (“Morphic”), a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the closing of its ...

Morphic Therapeutic has lost another Big Pharma partner. Eleven months after AbbVie walked away, Johnson & Johnson has delivered the killer blow to its own already-diminishing ties to the biotech. J&J ...

AI tech developer and production studio Morphic is producing its first episodic anime series, “DQN,” from creator Kushagra Kushwaha, in partnership with Kushwaha’s Tokyo-based studio 4861.

WALTHAM, Mass.--(BUSINESS WIRE)--Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin drugs, announced today that it has completed a $51.5 million Series A ...

WALTHAM, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...